Loading clinical trials...
Loading clinical trials...
The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
NCT05507879 · Breast Carcinoma, Cardiomyopathy, and more
NCT04551560 · Congestive Heart Failure
NCT07284446 · Congestive Heart Failure Chronic, Cognitive Impairment, Mild, and more
NCT07101289 · Congestive Heart Failure Chronic
NCT00762333 · Myocardial Infarction, Ischemia, and more
Desert Cardiology of Tucson
Tucson, Arizona
Arkansas Heart
Little Rock, Arkansas
San Diego Cardiac Center
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions